Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2025-10-08 00:00:00 ET · period of report 2025-10-06 · accession 0001193125-25-234881 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-10-08 | 2025-10-06+ | AXSM | TABUTEAU HERRIOT | CEO, Dir, 10% | M - OptEx | $8.02 | +45.4K | 26.4K | New | +$364.0K |
| DMT | 2025-10-08 | 2025-10-06+ | AXSM | TABUTEAU HERRIOT | CEO, Dir, 10% | S - Sale+OE | $119.38 | -45.4K | 7,229 | -86% | -$5.42M |
| DMT | 2025-10-08 | 2025-10-06+ | AXSM | TABUTEAU HERRIOT | CEO, Dir, 10% | M - OptEx | $0.00 | -45.4K | 441.9K | -9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-07 | M | A | 13,390 | $8.02 | 20,619 | D | — | — | |
| 2 | Common | Common Stock | 2025-10-07 | S | D | 13,390 | $118.77 | 7,229 | D | — | — | (F5) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $117.53 and $119.66. |
| 3 | Common | Common Stock | 2025-10-08 | M | A | 12,774 | $8.02 | 20,003 | D | — | — | |
| 4 | Common | Common Stock | 2025-10-08 | S | D | 12,774 | $118.84 | 7,229 | D | — | — | (F6) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $117.73 and $119.96. |
| 5 | Common | Common Stock | 2025-10-06 | M | A | 19,220 | $8.02 | 26,449 | D | — | — | |
| 6 | Common | Common Stock | 2025-10-06 | S | D | 19,220 | $120.17 | 7,229 | D | — | — | (F4) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $119.62 and $120.67. |
| 7 | Derivative | Stock Option (Right to Buy) | 2025-10-07 | M | D | 13,390 | $0.00 | 428,510 | D | $118.77 · 2017-05-27 to 2026-05-27 | 13,390 Common Stock | |
| 8 | Derivative | Stock Option (Right to Buy) | 2025-10-08 | M | D | 12,774 | $0.00 | 415,736 | D | $118.84 · 2017-05-27 to 2026-05-27 | 12,774 Common Stock | |
| 9 | Derivative | Stock Option (Right to Buy) | 2025-10-06 | M | D | 19,220 | $0.00 | 441,900 | D | $120.17 · 2017-05-27 to 2026-05-27 | 19,220 Common Stock |